Kyowa Kirin Co., Ltd. is a Japanese pharmaceutical company that specializes in the development and manufacturing of biopharmaceuticals and regenerative medicine products. The company was founded in 1949 as Kyowa Hakko Kogyo Co., Ltd. and changed its name to Kyowa Kirin Co., Ltd. in 2008. Kyowa Kirin Co., Ltd. operates in Asia, Europe, and North America and has a portfolio of products that includes treatments for cancer, kidney disease, and immune disorders.